{
  "docId": "019de06f-5896-7649-985b-a047bf109b4e",
  "docSlug": "0679cfa5b71d2595d2aa08ef14ddbab6",
  "documentTitle": "Pershing Square | Activist Presentation Deck | 39 slides",
  "authorId": "pershing-square",
  "authorName": "Pershing Square Capital Management, L.P.",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 5,
  "pageCount": 39,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "establish_context",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide outlines the core pillars of the Valeant business model, including M&A-led growth and leverage.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-5896-7649-985b-a047bf109b4e/5",
  "deckHref": "/decks/019de06f-5896-7649-985b-a047bf109b4e",
  "deckJsonHref": "/decks/019de06f-5896-7649-985b-a047bf109b4e.json",
  "deckAnchorHref": "/decks/019de06f-5896-7649-985b-a047bf109b4e#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "Pearson changed Valeant's strategy to incorporate:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84d94228-b35a-4169-8300-bd751dcd5786",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.86,
        "x": 0.1,
        "y": 0.3
      },
      "kind": "list",
      "text": "A durable, diverse portfolio of products in specialties where doctors are decision makers, with limited government reimbursement\nDecentralized, efficient, nimble organizational structure\nReturn-driven capital allocation framework (M&A, high ROI R&D, buybacks)\nRapid growth\nDiverse portfolio of products\nNumerous drivers of value creation\nNumerous acquisitions\nPurchased distressed assets, inherited multiple Corporate Integrity Agreements\nUtilized leverage",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7beb2c7-128b-4874-93f5-cc8b51187f79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "list",
      "text": "In February 2008, when Mike Pearson was named CEO, Valeant was a small, struggling company",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2c6c43c-f8ee-4d26-aae2-c41a41c23846",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.65,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Valeant: Context on the Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb72ba5b-6d6f-48e7-b46a-7e6628d9c79c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "d21d14d4-2d6f-4581-bb62-41ef933202c9",
      "evidence": "title/headline: Valeant: Context on the Company",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "capital-allocation-framework",
      "slug": null,
      "matchId": "09b7de54-8304-4713-a870-95399f09461c",
      "evidence": "Mentions 'Return-driven capital allocation framework (M&A, high ROI R&D, buybacks)'",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 1,
      "beatId": "d392f7eb-c0e0-42c0-9692-85c2dff6039b",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Ordinary World",
      "beatSlug": "heros-journey-ordinary-world",
      "evidence": "Introduction to Valeant Pharmaceuticals and context on the company",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}